Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Karina Vazquez-Arreguin"'
Autor:
Karina Vazquez-Arreguin, Yoshihiro Otani, Kimberly Rivera-Caraballo, Pei Guangsheng, Zhao Zhongming, Balveen Kaur
Publikováno v:
Neuro-Oncology. 24:vii1-vii1
Glioblastoma (GBM) is the most aggressive brain malignancy, which despite continuing worldwide efforts to develop new therapies, remains a deadly disease with limited treatment options. The asparagine hydroxylase factor inhibiting HIF (FIH1) is locat
Autor:
Jessica Swanner, Ji Seon Shim, Kimberly A. Rivera-Caraballo, Karina Vázquez-Arreguín, Bangxing Hong, Alberto J. Bueso-Perez, Tae Jin Lee, Yeshavanth Kumar Banasavadi-Siddegowda, Balveen Kaur, Ji Young Yoo
Publikováno v:
Molecular Therapy: Oncolytics, Vol 28, Iss , Pp 171-181 (2023)
High-mobility group box 1 (HMGB1) is a damage-associated molecular pattern (DAMP) molecule that plays an important role in inflammation and tumorigenesis. Receptor for advanced glycation end products (RAGE) is one of the major receptors to which extr
Externí odkaz:
https://doaj.org/article/435bf377912141fdaa13938aa81f5255
Autor:
Karina Vázquez-Arreguín, Balveen Kaur
Publikováno v:
Molecular Therapy: Oncolytics, Vol 29, Iss , Pp 15-16 (2023)
Externí odkaz:
https://doaj.org/article/0f652556034f448993e7cb431b4abdd7
Autor:
Karina Vázquez-Arreguín, Claire Bensard, John C Schell, Eric Swanson, Xinjian Chen, Jared Rutter, Dean Tantin
Publikováno v:
PLoS Genetics, Vol 15, Iss 5, p e1007687 (2019)
The transcription factor Oct1/Pou2f1 promotes poised gene expression states, mitotic stability, glycolytic metabolism and other characteristics of stem cell potency. To determine the effect of Oct1 loss on stem cell maintenance and malignancy, we del
Externí odkaz:
https://doaj.org/article/16666d1fc9f34cec854d9be1d8d14776